Notably, recent findings by Tsai’s group [53] demonstrated that ASPM enhances a stem cell phenotype in prostate cancer cells by augmenting Wnt/β-catenin signaling, thereby promoting tumor aggressiveness. This evidence concerns the gene ASPM and prostate cancer.